The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

FREMONT, Calif., May 18, 1999 -- Abgenix, Inc. (Nasdaq: ABGX) reported today additional results of a Phase II clinical trial of ABX-CBL in graft versus host disease ("GVHD"). ABX-CBL is a proprietary in-licensed mouse antibody that binds to the CBL antigen. The CBL antigen is upregulated on activated immune cells, including T cells, B cells and natural killer cells. The completed trial involved patients in four dose cohorts with severe GVHD, an often fatal side effect of bone marrow transplants ("BMT"). Among patients in the three higher dose cohorts, 56% (10 of 18) survived at least 100 days from the start of treatment with ABX-CBL. This compared favorably to a 22% (2 of 9) survival rate in the low dose cohort. Robert Rivkin, M.D. of the Rocky Mountain Cancer Centers in Denver, Colorado, presented the details of the clinical trial today at the 1999 Annual Meeting of the American Society of Clinical Oncology.

"We believe the survival data reported today strengthens the preliminary safety and response rate data reported earlier," stated R. Scott Greer, president and chief executive officer of Abgenix. "We plan to initiate a pivotal Phase III clinical trial for ABX-CBL as soon as feasible after we have approval from the FDA to proceed."

In March, at the International Bone Marrow Transplant Registry ("IBMTR") meeting, it was reported that, among patients in the three higher dose cohorts, 73% (11 of 15) had a two grade or better improvement in the IBMTR GVHD Severity Scale. This compared favorably to a 25% (2 of 8) response rate in the low dose cohort.

GHVD is a life threatening complication that frequently occurs following an allogeneic BMT. BMTs are used in the treatment of patients with end stage leukemia, certain other serious cancers and immune system disorders. An allogeneic BMT procedure involves transferring marrow, the graft, from a healthy person into an immunosuppressed patient, the host. The transplant is intended to restore nor
'"/>

Contact: Page Sargisson
p.sargisson@noonanrusso.com
415-677-4455 x229
Noonan/Russo Communications
18-May-1999


Page: 1 2

Related medicine news :

1. Melanoma Patients Sentinel Lymph Nodes (SLNS) Play A Strong Role In Disease Prognosis, UCSF Study Reports
2. Irritable Bowel Syndrome The Focus Of Three UNC-CH Reports At Digestive Diseases Conference
3. UCSF-Harvard Team Reports Encouraging Results In Drug Study Of Mice With Cancer
4. Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
6. BioNumerik Reports Data On Two Novel Supercomputer Engineered Anticancer Agents At 90th Annual Meeting Of The AACR
7. Changes In Levels Of LDLc From Pre- To Post-Menopausal Years Not Valuable Indicator Of Heart Disease, Reports University Of Pittsburgh Researcher
8. Medicare Policy Contradicts Preferred Treatment For Precancerous Skin Conditions, Westwood Squibb Center For Dermatology Research Reports
9. BioNumerik Reports The Supercomputer Supported Discovery Of New, Non-Toxic Chemotherapy Protecting Agent
10. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
11. ONYX Pharmaceuticals Reports Phase II Clinical Trial Results At ASCO Meeting

Post Your Comments:
(Date:11/25/2009)...e/--/EINNews/EINNews,anonlineleaderinindustrynewsm...alth-relatedpublicationforindustryprofessionalsand... ,, H1N1NewsTodaygathersthelatestinformationont...searchcenterstheworldover,searchingbeyondthefrontp...portsfromeverystateandeverycountry. ,, Diggingb...
(Date:11/25/2009)...tCall/--ErnestB.Remo,Chairman/CEOof AmericanDivers...edtodaythatitsnewwebsitewentlive.Itincludesaninves...sstimelyinformationandsignuptoreceiveemailnewsaler...ndiversifiedholdings.com ,, "Shareholdercommun...erelevantinformationtoshareholdersinmuchgreaterdep...
(Date:11/25/2009)...ioxide and other greenhouse emissions will have ma... the risk of climate change, especially in low-inc... appearing today (Wed., Nov. 25) in the British jo...ia, Berkeley, authors of the papers - Kirk R. Smit...ichael Jerrett, associate professor of environment...
(Date:11/25/2009)...timate effects of normal aging , , WEDNE...a time of eating turkey, gathering with family -- ... emergency room. , According to a New York City...ve not seen each other in months gather during the...lth of their older relatives and rush them to the ...
(Date:11/25/2009)... -LatestSurveyFromTheITJobBoardRevealsThat93Percen..., 81percentofITprosbelievetheirjobhasanimpact...ITJobBoard, http://www.theitjobboard.co.uk .And,n...ctisanegativeone. , Morethanhalf(57percent),s...elastyear-sincetherecessionbegan. , Whenasked...
Breaking Medicine News(10 mins):Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2Health News:American Diversified Holdings Corporation Announces New Website 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 3Health News:ER Visits for Elderly Rise During Thanksgiving 2Health News:ER Visits for Elderly Rise During Thanksgiving 3Health News:It's Official, Work is Bad for Our Health! 2
(Date:11/25/2009)...ov.25/PRNewswire/--AccordingtoMillenniumResearchGr...etintelligence,thenearly$3billionUSmarketfortrauma...nextfiveyearsdespitetherecenteconomicslowdown.MRG,...hismarketwillremainhighlydynamicoverthenextfiveyea...reviouslyunderservedsegmentsofthetraumafixationmar...
(Date:11/25/2009)...,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.toda...efexecutiveofficer,willpresentatthePiperJaffray21s...,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fern...antibioticclinicalprogramsforthetreatmentofdrug-re...harmaceuticals ,, Foundedin2006,CempraPharmace...
(Date:11/25/2009)...PRNewswire/--Reportlinker.comannouncesthatanewmark...IntranasalDrugDelivery-USMarketTrends&Analysis...Drug-Delivery---US-Market-Trends--Analysis.html ,...anexpansionoftherapeuticapplicationsfromthedeliver...fsystemictherapeuticdrugs.Thefutureofthetechnology...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5French Physicians to Conduct 2000 Patient Study of CATANIA 28TM 29 Coronary Stent 14671 1French Physicians to Conduct 2000 Patient Study of CATANIA 28TM 29 Coronary Stent 14671 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Antibiotic Resistance Still a Major Public Health Threat 60427 1Antibiotic Resistance Still a Major Public Health Threat 60427 2Antibiotic Resistance Still a Major Public Health Threat 60427 3Antibiotic Resistance Still a Major Public Health Threat 60427 4
Other News:
...l Medicine is published by the American College of...(ACP-ASIM), an organization of more than 115,000 i...The following highlights are not intended to subst...an embargoed fax of an article, call 1-800-523-154...
...ancy in England and Wales: follow up at age 5 year...bacterial meningitis in infancy BMJ Volume 323, pp...irst year of life have a 10-fold increased risk of...ompared with other children, concludes a study in ...
...ionality" (NE) reflects a tendency toward depressi...studies have shown that adolescents with alcohol u...ms than 'normal' adolescents do....A new study has... more health problems than supported by laboratory...
...The American College of Nuclear Physicians (ACNP) ...ld the Director of the Office of Management and Bu... (OIRA) that it welcomed his expression of concern...byproduct materials may not justify the costs of t...
health news:Annals of Internal Medicine, Tip Sheet, September 4, 2001 2health news:Annals of Internal Medicine, Tip Sheet, September 4, 2001 3health news:Meningitis in infancy linked to developmental problems 2health news:How 'negative emotionality' can make you feel sick 2health news:How 'negative emotionality' can make you feel sick 3health news:SNM reaction to OMB position on nuclear byproduct materials 2
HOBOKEN, N.J. -- Dr. S. Vincent Grasso, an adjunct professor of Chemistry and Chemical Biology at Stevens Institute of Technology and founder of Technology Integrations for Medical Applications, Inc.
...e very young and/or Hispanic have a greater chance... to a study done in part by the University of Albe...tient information gathered by the North American P...ealed that age, race, the cause of the kidney fail...
WASHINGTON, Aug. 22 A new imaging procedure may reduce the risk of esophageal injury in patients undergoing catheter ablation for atrial fibrillation (AF), according to a study published in the Septe
...cerning the recent outbreak of the corneal infecti...se of a specific contact lens solution, according ...r preliminary findings from this investigation wer...the market worldwide.... Among the estimated 34 mi...
health news:Grasso, Stevens alumni deploy next generation information systems platform 2health news:Hispanic and young children with kidney disease likely to be short 2health news:Imaging technique may prevent injury during ablation for atrial fibrillation 2health news:Report issued on outbreak of serious eye infection linked with use of certain contact lens solution 2